Clinical manifestations and end-organ effects associated with abnormal gonadotrophin release.
D000328:Adult; D000818:Animals; D001940:Breast / Q000503:physiopathology; D001941:Breast Diseases / Q000503:physiopathology*; D001943:Breast Neoplasms / Q000503:physiopathology; D004717:Endometrium / Q000503:physiopathology; D005187:Fallopian Tubes / Q000503:physiopathology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D005687:Galactorrhea / Q000503:physiopathology; D005831:Genital Diseases, Female / Q000503:physiopathology*; D006062:Gonadotropins / Q000378:metabolism*; D000882:Haplorhini; D006801:Humans; D007231:Infant, Newborn; D007986:Luteinizing Hormone / Q000378:metabolism; D008599:Menstruation Disturbances; D009215:Myometrium / Q000503:physiopathology; D010053:Ovary / Q000503:physiopathology; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism; D014599:Uterus / Q000098:blood supply / Q000503:physiopathology; D014621:Vagina / Q000503:physiopathology
D006062:Gonadotropins; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone